Does CAPLACIZUMAB Cause Haemorrhage? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Haemorrhage have been filed in association with CAPLACIZUMAB (Cablivi). This represents 6.2% of all adverse event reports for CAPLACIZUMAB.
9
Reports of Haemorrhage with CAPLACIZUMAB
6.2%
of all CAPLACIZUMAB reports
1
Deaths
4
Hospitalizations
How Dangerous Is Haemorrhage From CAPLACIZUMAB?
Of the 9 reports, 1 (11.1%) resulted in death, 4 (44.4%) required hospitalization, and 2 (22.2%) were considered life-threatening.
Is Haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPLACIZUMAB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does CAPLACIZUMAB Cause?
Off label use (26)
Condition aggravated (13)
Platelet count decreased (12)
Drug ineffective (10)
Maternal exposure during pregnancy (10)
Pyrexia (10)
Thrombotic thrombocytopenic purpura (10)
Foetal exposure during pregnancy (9)
Foetal growth restriction (9)
Deep vein thrombosis (8)
What Other Drugs Cause Haemorrhage?
RIVAROXABAN (6,571)
APIXABAN (4,770)
EMICIZUMAB-KXWH (3,612)
WARFARIN (2,930)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (2,925)
ASPIRIN (2,878)
ADALIMUMAB (2,681)
IBRUTINIB (1,907)
CLOPIDOGREL BISULFATE (1,762)
INSULIN LISPRO (1,614)
Which CAPLACIZUMAB Alternatives Have Lower Haemorrhage Risk?
CAPLACIZUMAB vs CAPLACIZUMAB-YHDP
CAPLACIZUMAB vs CAPMATINIB
CAPLACIZUMAB vs CAPREOMYCIN
CAPLACIZUMAB vs CAPSAICIN
CAPLACIZUMAB vs CAPTOPRIL